Company Filing History:
Years Active: 2003-2016
Title: Innovations and Contributions of Inventor Kathy Sutton
Introduction
Kathy Sutton is a notable inventor based in Herts, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target voltage-gated calcium channels. With a total of 2 patents, her work has implications for pain management and central nervous system disorders.
Latest Patents
Kathy Sutton's latest patents include the invention of fluoromethyl-substituted pyrrole carboxamides. This invention relates to pyrrole carboxamides bearing a fluoromethyl-moiety, which serve as voltage-gated calcium channel blockers. These compounds are also formulated into pharmaceutical compositions for the treatment and/or prophylaxis of pain and other diseases and disorders. Another significant patent involves methods to identify compounds that affect the expression level of the syntaxin-1A encoding gene. This research highlights a specific amino acid sequence that mediates the expression of the gene encoding syntaxin-1A, providing valuable insights for screening assays targeting the central nervous system.
Career Highlights
Throughout her career, Kathy has worked with prominent organizations, including Grünenthal GmbH and the University of British Columbia. Her experience in these institutions has allowed her to collaborate on innovative projects that advance medical science.
Collaborations
Kathy has collaborated with notable colleagues such as Stefan Schunk and Melanie Reich. These partnerships have contributed to her success and the development of her patented inventions.
Conclusion
Kathy Sutton's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical research. Her work continues to impact the treatment of pain and central nervous system disorders.